INLURIYO

IMLUNESTRANT · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for INLURIYO, covering 2025-09-25 to 2026-02-23. Get the full timeline:

Most recent: EMA Authorised: Inluriyo (imlunestrant tosilate) — Eli Lilly Nederland B.V.